Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 70858 CHARLOTTE, NC
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,946,183
-$14,982,176 QoQ
Shares Held
663,163
-29.2% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Sep 30, 2025
CallValue
$1,901,016
CallShares
35,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. BMRN ranks #58 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in BMRN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,946,183 663,163
2026-03-31 $52,928,359 936,951
2025-12-31 $51,377,944 864,512
2025-09-30 $1,901,016 35,100
2025-09-30 $51,428,437 949,565
2025-06-30 $1,868,980 34,000
2025-06-30 $44,056,857 801,471
2025-03-31 $2,403,460 34,000
2025-03-31 $51,848,848 733,468
2024-12-31 $4,377,618 66,600
2024-12-31 $33,379,332 507,825
2024-09-30 $63,259,520 899,979
2024-09-30 $3,837,834 54,600
2024-06-30 $11,526,200 140,000
2024-06-30 $84,266,562 1,023,522
2024-06-30 $4,495,218 54,600
2024-03-31 $28,472,840 326,000
2024-03-31 $243,650,036 2,789,673
2023-12-31 $3,278,280 34,000
2023-12-31 $227,441,759 2,358,865
2023-09-30 $211,929,150 2,395,221
2023-06-30 $2,071,652 23,900
2023-06-30 $317,260,933 3,660,140
2023-03-31 $10,774,192 110,800
2023-03-31 $341,879,305 3,515,830
2022-12-31 $7,792,797 75,300
2022-12-31 $118,538,891 1,145,414
2022-09-30 $103,716,515 1,223,505
2022-09-30 $6,383,181 75,300
2022-06-30 $2,303,786 27,800
2022-06-30 $98,335,277 1,186,621
2022-06-30 $2,361,795 28,500
2022-03-31 $93,024,771 1,206,547
2022-03-31 $61,680 800
2021-12-31 $150,195 1,700
2021-12-31 $70,680 800
2021-12-31 $147,003,795 1,663,880
2021-09-30 $115,935 1,500
2021-09-30 $132,119,136 1,709,395
2021-06-30 $3,571,232 42,800
2021-06-30 $142,744,226 1,710,741
2021-06-30 $125,160 1,500
2021-03-31 $141,001,254 1,867,319
2021-03-31 $10,193,850 135,000
2021-03-31 $113,265 1,500
2020-12-31 $4,384,500 50,000
2020-12-31 $2,227,326 25,400
2020-12-31 $158,919,179 1,812,284
2020-09-30 $143,023,245 1,879,906
2020-09-30 $4,085,496 53,700

Report a Problem

Category
Description
Email (optional, for follow-up)